Oncohematologist, transplantation specialist
Read moreOncohematologist, transplantation specialist
Pediatric hematologist-oncologist, transplant specialist
Read morePediatric hematologist-oncologist, transplant specialist
Doctor's visit | price on request |
$190000 - $200000 | |
transplantation from a related donor | |
transplantation from an unrelated donor | $132969 - $200000 |
Dr. Irina Zaidman is a Pediatric Hematology and Oncology specialist at the Hadassah Medical Center. She has extensive experience and training in pediatric residency, pediatric hemato-oncology, pediatric , and is a board member of the Israeli Pediatric Hemato-Oncology Society. She is active in teaching and has published several articles in the field of pediatric transplantations.
Read moreDr. Irina Zaidman is a Pediatric Hematology and Oncology specialist at the Hadassah Medical Center. She has extensive experience and training in pediatric residency, pediatric hemato-oncology, pediatric , and is a board member of the Israeli Pediatric Hemato-Oncology Society. She is active in teaching and has published several articles in the field of pediatric transplantations.
Doctor's visit | price on request |
$190000 - $200000 | |
transplantation from a related donor | |
transplantation from an unrelated donor | $132969 - $200000 |
Professor Drach is a specialist in oncology with a PhD from the Medical University of Vienna. He has experience in research, internal medicine, hematologic oncology, nutrition, and lifestyle in cancer. He is the Director of the Josefstadt Private Clinic in Vienna and a member of the Board of Directors of the Austrian Society of Hematology and Oncology. He has published more than 120 scientific papers and given more than 200 lectures/presentations.
Read moreProfessor Drach is a specialist in oncology with a PhD from the Medical University of Vienna. He has experience in research, internal medicine, hematologic oncology, nutrition, and lifestyle in cancer. He is the Director of the Josefstadt Private Clinic in Vienna and a member of the Board of Directors of the Austrian Society of Hematology and Oncology. He has published more than 120 scientific papers and given more than 200 lectures/presentations.
Oncologist, oncohematologist, transplant specialist
Read moreOncologist, oncohematologist, transplant specialist
Doctor's visit | price on request |
$137000 - $170000 |
Doctor's visit | price on request |
transplantation from a related donor | $20500 - $22500 |
$15000 - $35000 | |
transplantation from an unrelated donor | $37500 - $39000 |
Doctor's visit | price on request |
transplantation from a related donor | $20500 - $22500 |
$15000 - $35000 | |
transplantation from an unrelated donor | $37500 - $39000 |
Dr. Yener Koc is a highly experienced and award-winning transplant specialist, trained in the USA. He has provided over 1,900 transplants and achieved long-term survival rates of 66-90% for various conditions, with a mortality rate of 0.5-9%. He has authored over 230 scientific publications and been an inspector for the European Bone Marrow Transplant Centers since 2004.
Read moreDr. Yener Koc is a highly experienced and award-winning transplant specialist, trained in the USA. He has provided over 1,900 transplants and achieved long-term survival rates of 66-90% for various conditions, with a mortality rate of 0.5-9%. He has authored over 230 scientific publications and been an inspector for the European Bone Marrow Transplant Centers since 2004.
Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on " Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Cell Research Board. He is the founding president of the FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Cell Transplantation (, )
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.
Read moreProf. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on " Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Cell Research Board. He is the founding president of the FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Cell Transplantation (, )
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.
Membership in societies:
German Society of Oncology and Haemato-oncology GDHO
German Association of Physicians
American Association for Cancer Research
Expert in scientific journals
Close collaboration with leading haematologists
Involved in molecular biology research on the treatment of haemato-oncological diseases
Specialization:
Comprehensive treatment of tumour diseases, in particular chemotherapy, immunotherapy, immunotherapy, targeted therapy, radiation therapy molecular diagnostics.
Work experience:
2006: Graduation from the Faculty of Medicine of the University of Köln
2011: Specialization ‘Haematologist, Oncologist and Immunologist’
2011: Deputy Chief Physician of the Pulmonology Clinic Köln, Haematologist, Oncologist and Immunologist. Cologne, Haemato-oncologist and senior palliative care physician
2016: Qualification as a specialist in genetics
2021: Chief Physician of the Clinic for Haematology, Oncology and Palliative Care at the certified interdisciplinary cancer centre BKZ Solingen.
Dr. Fox is also actively involved in molecular biology research to develop and implement innovative treatments for haemato-oncological diseases. Her scientific work in this area has contributed to significant advances in understanding the molecular mechanisms of cancer and the development of effective therapies.
Dr. Fox specializes in the comprehensive treatment of tumour diseases, including chemotherapy, immunotherapy, targeted therapies, radiation therapy and molecular diagnostics.
Throughout her career, Dr. Fox has proven herself to be an outstanding specialist, constantly innovating treatment methods and approaches. Her patients receive the most effective and state-of-the-art treatments, which has earned her recognition and respect amongst colleagues and patients alike.
Read moreMembership in societies:
German Society of Oncology and Haemato-oncology GDHO
German Association of Physicians
American Association for Cancer Research
Expert in scientific journals
Close collaboration with leading haematologists
Involved in molecular biology research on the treatment of haemato-oncological diseases
Specialization:
Comprehensive treatment of tumour diseases, in particular chemotherapy, immunotherapy, immunotherapy, targeted therapy, radiation therapy molecular diagnostics.
Work experience:
2006: Graduation from the Faculty of Medicine of the University of Köln
2011: Specialization ‘Haematologist, Oncologist and Immunologist’
2011: Deputy Chief Physician of the Pulmonology Clinic Köln, Haematologist, Oncologist and Immunologist. Cologne, Haemato-oncologist and senior palliative care physician
2016: Qualification as a specialist in genetics
2021: Chief Physician of the Clinic for Haematology, Oncology and Palliative Care at the certified interdisciplinary cancer centre BKZ Solingen.
Dr. Fox is also actively involved in molecular biology research to develop and implement innovative treatments for haemato-oncological diseases. Her scientific work in this area has contributed to significant advances in understanding the molecular mechanisms of cancer and the development of effective therapies.
Dr. Fox specializes in the comprehensive treatment of tumour diseases, including chemotherapy, immunotherapy, targeted therapies, radiation therapy and molecular diagnostics.
Throughout her career, Dr. Fox has proven herself to be an outstanding specialist, constantly innovating treatment methods and approaches. Her patients receive the most effective and state-of-the-art treatments, which has earned her recognition and respect amongst colleagues and patients alike.
1989: Graduated from Cerrahpaşa Faculty of Medicine
1990 to 1995: Specialization in Pediatrics, Dr. Sami Ulus Pediatrics Training and Research Hospital
2000 to 2004: Specialization in Pediatric Oncology, Dr. Sami Ulus Children’s Hospital
2012: Awarded the title of Associate Professor
2012: Obtained the title of Hematology-Oncology Specialist
2019: Appointed Professor at Istinye University Faculty of Medicine
1989 to 1990: Compulsory service at Edirne/Keşan/Suluca Health Care Center
1995 to 1996: Completed military service
1996 to 2000: Pediatrics Specialist, Çorum/Sungurlu State Hospital
2004: Temporary assignment at Ankara Oncology Hospital, Pediatric Oncology Department
2004 to 2014: Pediatric Oncology Specialist at Dr. Sami Ulus Children’s Hospital
2008: Training at Children’s Bone Marrow Transplantation Unit, Gülhane Military Medical Academy (3 months)
2008 to 2009: Observer at Pediatric Cell Transplant Center, Cincinnati Children's Hospital, Ohio State, USA
2010: Observer at Pediatric Neuro-Oncology Department, Dana-Farber Cancer Institute, Harvard University
2011: Worked at Pediatric Bone Marrow Transplantation Unit, Ankara Pediatric Hematology-Oncology Hospital
2012 to 2014: Administrative Chief, Pediatric Hematology-Oncology Clinic, Dr. Sami Ulus Children’s Hospital
2014 to 2017: Pediatric Hematology-Oncology and Bone Marrow Transplantation Specialist at Bahçelievler Medical Park Hospital
2017-Present: Professor & Clinical Director, Pediatric Hematology-Oncology Clinic, Bahçelievler Medical Park Hospital
Vice Director, Cell Transplant Unit
-National Pediatrics Association
-Turkish Pediatric Oncology Group Association (TPOG)
-Turkish Pediatric Hematology Group, Pediatric KIT Subgroup
-International Pediatric Oncology Group (SIOP)
Authored and co-authored over 40 peer-reviewed scientific articles in renowned medical journals.
Key research areas:
Acute Lymphoblastic Leukemia & Pediatric Oncology
Bone Marrow Transplantation & Cell Therapy
Hematological Malignancies & Pediatric Hematology
Neuroblastoma & Childhood Cancers
Immunodeficiency & Pediatric Hematopoietic Cell Transplantation
For a full list of publications, please refer to indexed journals and medical databases.
Read more1989: Graduated from Cerrahpaşa Faculty of Medicine
1990 to 1995: Specialization in Pediatrics, Dr. Sami Ulus Pediatrics Training and Research Hospital
2000 to 2004: Specialization in Pediatric Oncology, Dr. Sami Ulus Children’s Hospital
2012: Awarded the title of Associate Professor
2012: Obtained the title of Hematology-Oncology Specialist
2019: Appointed Professor at Istinye University Faculty of Medicine
1989 to 1990: Compulsory service at Edirne/Keşan/Suluca Health Care Center
1995 to 1996: Completed military service
1996 to 2000: Pediatrics Specialist, Çorum/Sungurlu State Hospital
2004: Temporary assignment at Ankara Oncology Hospital, Pediatric Oncology Department
2004 to 2014: Pediatric Oncology Specialist at Dr. Sami Ulus Children’s Hospital
2008: Training at Children’s Bone Marrow Transplantation Unit, Gülhane Military Medical Academy (3 months)
2008 to 2009: Observer at Pediatric Cell Transplant Center, Cincinnati Children's Hospital, Ohio State, USA
2010: Observer at Pediatric Neuro-Oncology Department, Dana-Farber Cancer Institute, Harvard University
2011: Worked at Pediatric Bone Marrow Transplantation Unit, Ankara Pediatric Hematology-Oncology Hospital
2012 to 2014: Administrative Chief, Pediatric Hematology-Oncology Clinic, Dr. Sami Ulus Children’s Hospital
2014 to 2017: Pediatric Hematology-Oncology and Bone Marrow Transplantation Specialist at Bahçelievler Medical Park Hospital
2017-Present: Professor & Clinical Director, Pediatric Hematology-Oncology Clinic, Bahçelievler Medical Park Hospital
Vice Director, Cell Transplant Unit
-National Pediatrics Association
-Turkish Pediatric Oncology Group Association (TPOG)
-Turkish Pediatric Hematology Group, Pediatric KIT Subgroup
-International Pediatric Oncology Group (SIOP)
Authored and co-authored over 40 peer-reviewed scientific articles in renowned medical journals.
Key research areas:
Acute Lymphoblastic Leukemia & Pediatric Oncology
Bone Marrow Transplantation & Cell Therapy
Hematological Malignancies & Pediatric Hematology
Neuroblastoma & Childhood Cancers
Immunodeficiency & Pediatric Hematopoietic Cell Transplantation
For a full list of publications, please refer to indexed journals and medical databases.